Literature DB >> 3022376

Two avirulent herpes simplex viruses generate lethal recombinants in vivo.

R T Javier, F Sedarati, J G Stevens.   

Abstract

While it is widely appreciated that infection with a virulent virus can produce disease in an animal, the ability of a mixture of avirulent viruses to produce disease by means of complementation or recombination in vivo has not been established. In this study, two weakly neuroinvasive herpes simplex virus type 1 (HSV-1) strains were simultaneously inoculated onto the footpads of mice. Many (62%) of the animals that received a 1:1 mixture of the viruses died, whereas the animals that received a similar or 100-fold higher dose of each agent alone survived. Of fourteen viruses isolated from the brains of ten mice that died after receiving the mixture of the two weakly neuroinvasive viruses, eleven were recombinants; three of these recombinants were lethal when reapplied to the footpads of mice. These results show that two avirulent HSV-1 variants may interact in vivo to produce virulent recombinants and a lethal infection. They also suggest that different genetic lesions account for the weakly neuroinvasive character of the HSV-1 strains ANG and KOS after footpad inoculation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022376     DOI: 10.1126/science.3022376

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  44 in total

1.  Experimental in vivo generation of intertypic recombinant strains of HSV in the mouse.

Authors:  D L Yirrell; C E Rogers; W A Blyth; T J Hill
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  A full-genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades.

Authors:  Geoffrey A Peters; Shaun D Tyler; Charles Grose; Alberto Severini; Michael J Gray; Chris Upton; Graham A Tipples
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 3.  RNA recombination in animal and plant viruses.

Authors:  M M Lai
Journal:  Microbiol Rev       Date:  1992-03

4.  Complementary lethal invasion of the central nervous system by nonneuroinvasive herpes simplex virus types 1 and 2.

Authors:  Y Nishiyama; H Kimura; T Daikoku
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Using HSV-1 genome phylogenetics to track past human migrations.

Authors:  Aaron W Kolb; Cécile Ané; Curtis R Brandt
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

6.  Antibody-mediated targeted gene transfer of helper virus-free HSV-1 vectors to rat neocortical neurons that contain either NMDA receptor 2B or 2A subunits.

Authors:  Haiyan Cao; Guo-rong Zhang; Alfred I Geller
Journal:  Brain Res       Date:  2011-08-11       Impact factor: 3.252

7.  Unveiling of the diversity of Prasinoviruses (Phycodnaviridae) in marine samples by using high-throughput sequencing analyses of PCR-amplified DNA polymerase and major capsid protein genes.

Authors:  Camille Clerissi; Nigel Grimsley; Hiroyuki Ogata; Pascal Hingamp; Julie Poulain; Yves Desdevises
Journal:  Appl Environ Microbiol       Date:  2014-03-14       Impact factor: 4.792

8.  Deletion of Herpes Simplex Virus 1 MicroRNAs miR-H1 and miR-H6 Impairs Reactivation.

Authors:  Enrico R Barrozo; Sanae Nakayama; Pankaj Singh; Emilia A H Vanni; Ann M Arvin; Donna M Neumann; David C Bloom
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

9.  Interspecific recombination between two ruminant alphaherpesviruses, bovine herpesviruses 1 and 5.

Authors:  François Meurens; Günther M Keil; Benoît Muylkens; Sacha Gogev; Frédéric Schynts; Sandra Negro; Laetitia Wiggers; Etienne Thiry
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Herpes Simplex Virus 1 MicroRNA miR-H8 Is Dispensable for Latency and Reactivation In Vivo.

Authors:  Enrico R Barrozo; Sanae Nakayama; Pankaj Singh; Donna M Neumann; David C Bloom
Journal:  J Virol       Date:  2021-01-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.